How CEO Stonehouse is building up BioCryst's war chest to finance trials, drug launch

BioCryst pharmaceutical has extended an existing loan agreement to $100 million, hoping to extend its runway and finance through upcoming clinical trials and a new drug application,

Source: bizjournals.com Health Care:Physician Practices headlines - February 6, 2019 Category: American Health Authors: Seth Thomas Gulledge Source Type: news